Homeboy Joy Ride, produced by Paul Steinbroner and David Okimoto, is directed by Paul Steinbroner, an accomplished filmmaker with over thirty years experience specializing in topics

Homeboy Joy Ride, produced by Paul Steinbroner and David Okimoto, is directed by Paul Steinbroner, an accomplished filmmaker with over thirty years experience specializing in topics related to addiction, neuropharmacology, and brain chemistry. This film is one of six segments of the documentary series Called from Darkness. 

Homeboy Joy Ride trailer (3:07)

Download a Brief Overview of the film for more detail.

To buy a DVD of Homeboy Joy Ride visit Homeboy Industries online store here.

Interview with Dr.Janice MV Knox of American Cannabinoid Clinics by Doc Kelley.  A discussion of the importance of cannabis and our health.  For more information

Interview with Dr.Janice MV Knox of American Cannabinoid Clinics by Doc Kelley.  A discussion of the importance of cannabis and our health.  For more information visit the site of American Cannabinoid Clinics. 

Tora Fisher is a New York based singer-songwriter and performance artist. When she was young, her mother

Tora Fisher is a New York based singer-songwriter and performance artist. When she was young, her mother encouraged her to develop her artistic side while her father exposed her to a world outside of the arts: he created the Fisher House Foundation, a network of comfort homes where military and their families can stay at no cost while their loved ones receive care and treatment. Tora developed a keen interest in these two starkly different worlds: that of the arts, and the art of war.

When Tora was 13, she experienced the unfathomable when she was the sole survivor of a plane crash that killed her father, stepmother, and four others. Her resilience and determination to recover from this trauma was nurtured by her love of music and performance and her ability to pursue her dreams of being a singer-songwriter, pianist, dancer and recording artist. She has also fulfilled her dream of supporting her father's legacy by donating proceeds from her CDs to the Fisher House Foundation.

As Tora so aptly put it, "its not about what happened to me; it's about what's happening."Published on May 31, 2014

April 28, 2012 - Seventh National Clinical Conference on Cannabis Therapeutics, hosted by Patients Out of Time - Founder and Director of the Arizona Center for

April 28, 2012 - Seventh National Clinical Conference on Cannabis Therapeutics, hosted by Patients Out of Time - Founder and Director of the Arizona Center for Integrative Medicine, College of Medicine at the University of Arizona, Andrew Weil, MD talks about challenges and the future of natural cannabis and cannabinoids in modern medicine, citing opiod-sparing effect; spasticity relief; neurological benefits for MS and ALS; modulation and quality of life.
Then panel moderator Clint Werner asks Dr. Weil about his early research on cannabis.

April, 2008 - At Fifth National Clinical Conference on CannabisTherapeutics, April, 2008 in Pacific Grove, CA. Arno Hazecamp,

April, 2008 - At Fifth National Clinical Conference on CannabisTherapeutics, April, 2008 in Pacific Grove, CA. Arno Hazecamp, PhD, commission by the Dutch government's Office of Medicinal Cannabis, researches chemical composition of cannabis tea, finding relatively high concentrations of THCA (THC Acid) rather than THC (decarboxylated).
Conference sponsored by University of CA's School of Medicine, and by Patients out of Time -

Published on May 5, 2013

Donald Abrams, M.D. is chief of Hematology and Oncology at San

Donald Abrams, M.D. is chief of Hematology and Oncology at San Francisco General Hospital and the co-author—with Andrew Weil—of Integrative Oncology (Oxford University Press). Abrams has extensive experience working with cancer and HIV/AIDS patients and is a pioneer in the field of medical cannabis research.

The U.S. government classifies cannabis—along with heroin and LSD—as a Schedule I drug, the most tightly restricted category of drugs in the United States. According to the federal government, Schedule I drugs are unsafe and have "no currently accepted medical use in treatment in the United States."

However, as medical cannabis proponents have pointed out since the Controlled Substances Act was passed by Congress in 1970, cannabis has been used medicinally for thousands of years, and there has never been a reported case of a marijuana overdose. Moreover, in recent years clinical researchers around the world have demonstrated the medicinal value of cannabis. Uploaded on Oct 14, 2010